Nils Koch‐Henriksen

Clinical importance of neutralising antibodies against interferon beta in patients with relapsing-remitting multiple sclerosis

Per Soelberg Sørensen, Katja Maria Clemmesen, Klaus Bendtzen et al. · The Lancet · 2003 · 386 citations

Life Sciences, Immunology, Neurology +14

Demyelination versus remyelination in progressive multiple sclerosis

Stephan Bramow, Josa M. Frischer, Hans Lassmann et al. · Brain · 2010 · 311 citations

Life Sciences, Neurology, Neuroscience +17

Childhood body mass index and multiple sclerosis risk: a long-term cohort study

Kassandra L. Munger, Joan Bentzen, Bjarne Laursen et al. · Multiple Sclerosis Journal · 2013 · 298 citations

Public Health, Child Health, Pediatrics +14

Pain in Patients With Multiple Sclerosis

Kristina Bacher Svendsen, Troels S. Jensen, Kim Overvad et al. · Archives of Neurology · 2003 · 222 citations

Medicine, Neurology, Pain Management +8

Multiple Sclerosis After Infectious Mononucleosis

Trine Rasmussen Nielsen, Klaus Rostgaard, Nete Munk Nielsen et al. · Archives of Neurology · 2007 · 208 citations

Medicine, Infectious Diseases, Neurology +13